Glorious Biopharma-B to Reduce Stake by approximately 9.9% in a Share Placement and Conditional Subscription Agreement; Expected Net Proceeds of HK$4.68 billion
Glorious Biopharma-B (01672) published an announcement on August 19, 2025, disclosing that the company, the seller (JJW12 Limited), and the subscription agent have entered into a share placement and c